|
GS185131: GO:0044699 single-organism process
|
|
GS176836: HP:0000422 Abnormality of the nasal bridge
|
|
GS183514: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS170728: MP:0002565 delayed circadian phase
|
|
GS183848: GO:0044260 cellular macromolecule metabolic process
|
|
GS186757: GO:0034654 nucleobase-containing compound biosynthetic process
|
|
GS202082: GO:0051254 positive regulation of RNA metabolic process
|
|
GS174646: HP:0000951 Abnormality of the skin
|
|
GS164220: MP:0002882 abnormal neuron morphology
|
|
GS198685: GO:0048522 positive regulation of cellular process
|
|
GS136900: ventral midbrain iron content 4 (Vmbic4, Published QTL Chr 7)
|
|
GS201949: GO:0044699 single-organism process
|
|
GS208954: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS172666: HP:0011804 Abnormality of muscle physiology
|
|
GS185261: GO:0051254 positive regulation of RNA metabolic process
|
|
GS171644: HP:0011842 Abnormality of skeletal morphology
|
|
GS186526: GO:0005654 nucleoplasm
|
|
GS175107: HP:0003808 Abnormal muscle tone
|
|
GS203018: GO:0045935 positive regulation of nucleobase-containing compound metabolic process
|
|
GS190950: GO:0009059 macromolecule biosynthetic process
|
|
GS181568: GO:0006357 regulation of transcription from RNA polymerase II promoter
|
|
GS178461: GO:0009987 cellular process
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS136319: non-HDL QTL 6 (Nhdlq6, Published QTL Chr 7)
|
|
GS170108: MP:0003727 abnormal retinal layer morphology
|
|
GS135346: Avp transcript abundance QTL 1 (Avptaq1, Published QTL Chr 7)
|
|
GS181012: GO:0007423 sensory organ development
|
|
GS168338: MP:0001502 abnormal circadian rhythm
|
|
GS163581: MP:0001004 abnormal retinal photoreceptor morphology
|
|
GS166394: MP:0003728 abnormal retinal photoreceptor layer morphology
|
|
GS193268: GO:0005575 cellular_component
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS165142: MP:0003732 abnormal retinal outer plexiform layer morphology
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS172358: HP:0003117 Abnormality of circulating hormone level
|
|
GS199273: GO:0043233 organelle lumen
|
|
GS172363: HP:0004324 Increased body weight
|
|
GS176718: HP:0000078 Abnormality of the genital system
|
|
GS136745: spermatogenesis defect 3 (Spmd3, Published QTL Chr 7)
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS191019: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS176107: HP:0000929 Abnormality of the skull
|
|
GS187887: GO:0080090 regulation of primary metabolic process
|
|
GS172032: HP:0000366 Abnormality of the nose
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS168389: MP:0001186 pigmentation phenotype
|
|
GS175332: HP:0000032 Abnormality of male external genitalia
|
|
GS165466: MP:0003632 abnormal nervous system morphology
|
|
GS172843: HP:0000481 Abnormality of the cornea
|
|
GS189669: GO:2000112 regulation of cellular macromolecule biosynthetic process
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS206108: GO:2001141 regulation of RNA biosynthetic process
|
|
GS166388: MP:0006068 abnormal horizontal cell morphology
|
|
GS192017: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS170964: HP:0000152 Abnormality of head and neck
|
|
GS175674: HP:0007360 Aplasia/Hypoplasia of the cerebellum
|
|
GS191106: GO:0044464 cell part
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS173290: HP:0011354 Generalized abnormality of skin
|
|
GS174869: HP:0000551 Abnormality of color vision
|
|
GS177265: GO:0048731 system development
|
|
GS207925: GO:0034645 cellular macromolecule biosynthetic process
|
|
GS186227: GO:0090304 nucleic acid metabolic process
|
|
GS201251: GO:0044424 intracellular part
|
|
GS193238: GO:0031323 regulation of cellular metabolic process
|
|
GS172031: HP:0000364 Hearing abnormality
|
|
GS203908: GO:0016070 RNA metabolic process
|
|
GS181893: GO:0048522 positive regulation of cellular process
|
|
GS210485: GO:0007601 visual perception
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS188142: GO:0048856 anatomical structure development
|
|
GS136531: prion resistance 2 (Prnr2, Published QTL Chr 7)
|
|
GS167528: MP:0008519 thin retinal outer plexiform layer
|
|
GS171126: HP:0000022 Abnormality of male internal genitalia
|
|
GS174860: HP:0010549 Paralysis due to lesions of the principle motor tracts
|
|
GS166313: MP:0008450 retinal photoreceptor degeneration
|
|
GS209551: GO:0031981 nuclear lumen
|
|
GS136728: susceptibility to lung cancer 30 (Sluc30, Published QTL Chr 7)
|
|
GS168142: MP:0008583 absent photoreceptor inner segment
|
|
GS194555: GO:0031974 membrane-enclosed lumen
|
|
GS171848: HP:0000598 Abnormality of the ear
|
|
GS172516: HP:0001347 Hyperreflexia
|
|
GS193414: GO:0044249 cellular biosynthetic process
|
|
GS174378: HP:0000518 Cataract
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS197472: GO:0044451 nucleoplasm part
|
|
GS184629: GO:0005515 protein binding
|
|
GS209225: GO:0007600 sensory perception
|
|
GS172553: HP:0100689 Decreased corneal thickness
|
|
GS203525: GO:0043010 camera-type eye development
|
|
GS203607: GO:0034654 nucleobase-containing compound biosynthetic process
|
|
GS163971: MP:0002092 abnormal eye morphology
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS197802: GO:0007423 sensory organ development
|
|
GS173146: HP:0011282 Abnormality of the hindbrain
|
|
GS129070: allergen-induced bronchial hyperresponsiveness 3 (Abhr3 Published QTL Chr 7)
|
|
GS136264: modifier of mammary tumor progression 1 (Mmtp1, Published QTL Chr 7)
|
|
GS173703: HP:0000842 Hyperinsulinemia
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS180152: GO:0065007 biological regulation
|
|
GS163432: MP:0006069 abnormal retinal neuronal layer morphology
|
|
GS178922: GO:0003700 sequence-specific DNA binding transcription factor activity
|
|
GS173741: HP:0100699 Scarring
|
|
GS173091: HP:0004374 Hemiplegia/hemiparesis
|
|
GS187708: GO:0009893 positive regulation of metabolic process
|
|
GS136233: mandible length 7 (Manln7, Published QTL Chr 7)
|
|
GS204232: GO:0001071 nucleic acid binding transcription factor activity
|
|
GS166743: MP:0002229 neurodegeneration
|
|
GS186488: GO:0048513 organ development
|
|
GS172134: HP:0000639 Nystagmus
|
|
GS36763: Cerebellum Gene expression correlates of Vocalization Threshold - shock intensity (mA) in Males BXD
|
|
GS169095: MP:0004924 abnormal behavior
|
|
GS176203: HP:0000478 Abnormality of the eye
|
|
GS202899: GO:0050877 neurological system process
|
|
GS175373: HP:0011486 Abnormality of corneal thickness
|
|
GS172030: HP:0000365 Hearing impairment
|
|
GS172185: HP:0002977 Aplasia/Hypoplasia involving the central nervous system
|
|
GS170245: MP:0004022 abnormal cone electrophysiology
|
|
GS135458: bone mineral density 4 (Bomd4, Published QTL Chr 7)
|
|
GS171226: HP:0000812 Abnormal internal genitalia
|
|
GS173024: HP:0000811 Abnormal external genitalia
|
|
GS196806: GO:0032502 developmental process
|
|
GS204842: GO:0003682 chromatin binding
|
|
GS175492: HP:0000512 Abnormal electroretinogram
|
|
GS182595: GO:0019904 protein domain specific binding
|
|
GS193937: GO:0006366 transcription from RNA polymerase II promoter
|
|
GS203594: GO:0043226 organelle
|
|
GS205364: GO:0010467 gene expression
|
|
GS163166: MP:0006073 abnormal retinal bipolar cell morphology
|
|
GS172360: HP:0004323 Abnormality of body weight
|
|
GS174701: HP:0000556 Retinal dystrophy
|
|
GS171168: HP:0000234 Abnormality of the head
|
|
GS195643: GO:0003677 DNA binding
|
|
GS176096: HP:0000548 Cone-rod dystrophy
|
|
GS198572: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS190949: GO:0009058 biosynthetic process
|
|
GS128593: Average rotarod training latency Chr# 7
|
|
GS182705: GO:0051173 positive regulation of nitrogen compound metabolic process
|
|
GS195340: GO:0045893 positive regulation of transcription, DNA-dependent
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS136263: modifier of mammary tumor growth 3 (Mmtg3, Published QTL Chr 7)
|
|
GS171708: HP:0000359 Abnormality of the inner ear
|
|
GS167217: MP:0001325 abnormal retina morphology
|
|
GS186744: GO:0043226 organelle
|
|
GS209960: GO:0003008 system process
|
|
GS169828: MP:0005386 behavior/neurological phenotype
|
|
GS171047: HP:0008736 Hypoplasia of penis
|
|
GS172372: HP:0000648 Optic atrophy
|
|
GS182835: GO:0005622 intracellular
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS201265: GO:0009891 positive regulation of biosynthetic process
|
|
GS177308: GO:1901362 organic cyclic compound biosynthetic process
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS190016: GO:0001654 eye development
|
|
GS173988: HP:0000501 Glaucoma
|
|
GS206544: GO:2000112 regulation of cellular macromolecule biosynthetic process
|
|
GS182703: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS210178: GO:0031328 positive regulation of cellular biosynthetic process
|
|
GS176844: HP:0000429 Abnormality of the nasal alae
|
|
GS182194: GO:0005667 transcription factor complex
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS206897: GO:0001654 eye development
|
|
GS169804: MP:0003731 abnormal retinal outer nuclear layer morphology
|
|
GS166244: MP:0002752 abnormal somatic nervous system morphology
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS176231: HP:0010938 Abnormality of the external nose
|
|
GS198360: GO:0006357 regulation of transcription from RNA polymerase II promoter
|
|
GS203406: GO:0009653 anatomical structure morphogenesis
|
|
GS176744: HP:0000987 Atypical scarring of skin
|
|
GS184461: GO:0009891 positive regulation of biosynthetic process
|
|
GS136742: Streptococcus pneumoniae infection resistance 1 (Spir1, Published QTL Chr 7)
|
|
GS176988: HP:0008046 Abnormality of the retinal vasculature
|
|
GS186790: GO:0006725 cellular aromatic compound metabolic process
|
|
GS177356: GO:0003674 molecular_function
|
|
GS178885: GO:0003677 DNA binding
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS199501: GO:0051173 positive regulation of nitrogen compound metabolic process
|
|
GS174217: HP:0005105 Abnormal nasal morphology
|
|
GS171631: HP:0008051 Abnormality of the retinal pigment epithelium
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS206329: GO:0060255 regulation of macromolecule metabolic process
|
|
GS163943: MP:0005201 abnormal retinal pigment epithelium morphology
|
|
GS173019: HP:0000819 Diabetes mellitus
|
|
GS188410: GO:0032774 RNA biosynthetic process
|
|
GS170195: MP:0008515 thin retinal outer nuclear layer
|
|
GS195199: GO:0005634 nucleus
|
|
GS165985: MP:0000965 abnormal sensory neuron morphology
|
|
GS173666: HP:0005978 Type II diabetes mellitus
|
|
GS180166: GO:0008152 metabolic process
|
|
GS193234: GO:0031328 positive regulation of cellular biosynthetic process
|
|
GS135938: HDL level 38 (Hdl38, Published QTL Chr 7)
|
|
GS164446: MP:0005195 abnormal posterior eye segment morphology
|
|
GS135746: experimental allergic encephalomyelitis susceptibility 12 (Eae12, Published QTL Chr 7)
|
|
GS171855: HP:0000597 Ophthalmoparesis
|
|
GS163803: MP:0003631 nervous system phenotype
|
|
GS197112: GO:0043522 leucine zipper domain binding
|
|
GS169803: MP:0003730 abnormal photoreceptor inner segment morphology
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS198991: GO:0005667 transcription factor complex
|
|
GS171946: HP:0002269 Abnormality of neuronal migration
|
|
GS175500: HP:0000517 Abnormality of the lens
|
|
GS180673: GO:0044451 nucleoplasm part
|
|
GS173079: HP:0000496 Abnormality of eye movement
|
|
GS189240: GO:2001141 regulation of RNA biosynthetic process
|
|
GS203072: GO:0090304 nucleic acid metabolic process
|
|
GS166016: MP:0001324 abnormal eye pigmentation
|
|
GS128580: BECs at LORR Recovery Chr# 7
|
|
GS186178: GO:0045935 positive regulation of nucleobase-containing compound metabolic process
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS166716: MP:0003729 abnormal photoreceptor outer segment morphology
|
|
GS195678: GO:0003700 sequence-specific DNA binding transcription factor activity
|
|
GS171251: HP:0003549 Abnormality of connective tissue
|
|
GS187343: GO:0006351 transcription, DNA-dependent
|
|
GS135988: Hfe modifier 1 (Hfem1, Published QTL Chr 7)
|
|
GS173991: HP:0000505 Visual impairment
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS203369: GO:0005654 nucleoplasm
|
|
GS169531: MP:0005391 vision/eye phenotype
|
|
GS171815: HP:0001574 Abnormality of the integument
|
|
GS177031: HP:0011442 Abnormality of central motor function
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS172354: HP:0004328 Abnormality of the anterior segment of the eye
|
|
GS174505: HP:0000708 Behavioural/Psychiatric Abnormality
|
|
GS181473: GO:0005488 binding
|
|
GS205543: GO:0070013 intracellular organelle lumen
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS184445: GO:0044428 nuclear part
|
|
GS174836: HP:0001098 Abnormality of the fundus
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS192345: GO:0010628 positive regulation of gene expression
|
|
GS196930: GO:0065007 biological regulation
|
|
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS180330: GO:0043522 leucine zipper domain binding
|
|
GS165809: MP:0002864 abnormal ocular fundus morphology
|
|
GS187751: GO:0019222 regulation of metabolic process
|
|
GS177859: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
|
|
GS191150: GO:0010557 positive regulation of macromolecule biosynthetic process
|
|
GS171139: HP:0005288 Abnormality of the nares
|
|
GS193237: GO:0031325 positive regulation of cellular metabolic process
|
|
GS176171: HP:0001250 Seizures
|
|
GS195214: GO:0009987 cellular process
|
|
GS184452: GO:0044422 organelle part
|
|
GS204204: GO:0006351 transcription, DNA-dependent
|
|
GS172295: HP:0001513 Obesity
|
|
GS180034: GO:0032502 developmental process
|
|
GS200648: GO:0044260 cellular macromolecule metabolic process
|
|
GS135417: beta-carboline induced seizures 4 (Bis4, Published QTL Chr 7)
|
|
GS176170: HP:0001252 Muscular hypotonia
|
|
GS194602: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
|
|
GS204746: GO:0080090 regulation of primary metabolic process
|
|
GS166824: MP:0005103 abnormal retinal pigmentation
|
|
GS201249: GO:0044428 nuclear part
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS185259: GO:0051252 regulation of RNA metabolic process
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS176989: HP:0008047 Abnormality of the vasculature of the eye
|
|
GS193991: GO:0048731 system development
|
|
GS175714: HP:0011389 Functional abnormality of the inner ear
|
|
GS198456: GO:0019438 aromatic compound biosynthetic process
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS204694: GO:0060041 retina development in camera-type eye
|
|
GS136214: lupus BXSB x NZW 6 (Lxw6, Published QTL Chr 7)
|
|
GS169334: MP:0009389 abnormal extracutaneous pigmentation
|
|
GS181667: GO:0019438 aromatic compound biosynthetic process
|
|
GS198263: GO:0005488 binding
|
|
GS171512: HP:0007703 Abnormal retinal pigmentation
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS194088: GO:0003676 nucleic acid binding
|
|
GS175169: HP:0001317 Abnormality of the cerebellum
|
|
GS188511: GO:0010468 regulation of gene expression
|
|
GS175529: HP:0000001 All
|
|
GS176955: HP:0000431 Wide nasal bridge
|
|
GS190067: GO:0018130 heterocycle biosynthetic process
|
|
GS170971: HP:0000407 Sensorineural hearing impairment
|
|
GS175423: HP:0010461 Abnormality of the male genitalia
|
|
GS163138: MP:0005253 abnormal eye physiology
|
|
GS205266: GO:0032774 RNA biosynthetic process
|
|
GS171657: HP:0000613 Photophobia
|
|
GS175527: HP:0000006 Autosomal dominant inheritance
|
|
GS178589: GO:0045893 positive regulation of transcription, DNA-dependent
|
|
GS136894: ventricular size 3 (Vent3, Published QTL Chr 7)
|
|
GS184447: GO:0044424 intracellular part
|
|
GS179777: GO:0043565 sequence-specific DNA binding
|
|
GS172899: HP:0011815 Cephalocele
|
|
GS136253: modifier of Dlk1 (mdlk1, Published QTL Chr 7)
|
|
GS164692: MP:0004021 abnormal rod electrophysiology
|
|
GS172100: HP:0000587 Abnormality of the optic nerve
|
|
GS193236: GO:0031326 regulation of cellular biosynthetic process
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS210357: GO:0044249 cellular biosynthetic process
|
|
GS175597: HP:0011013 Abnormality of carbohydrate metabolism/homeostasis
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS173810: HP:0002597 Abnormality of the vasculature
|
|
GS174706: HP:0000553 Abnormality of the uvea
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS172353: HP:0004329 Abnormality of the posterior segment of the eye
|
|
GS136096: long bones 6 (Lbn6, Published QTL Chr 7)
|
|
GS182469: GO:0043234 protein complex
|
|
GS206953: GO:0018130 heterocycle biosynthetic process
|
|
GS136189: lipoprotein QTL 5 (Lprq5, Published QTL Chr 7)
|
|
GS191021: GO:0034645 cellular macromolecule biosynthetic process
|
|
GS199499: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS187835: GO:0060041 retina development in camera-type eye
|
|
GS203057: GO:0048518 positive regulation of biological process
|
|
GS84191: alcohol preference 7 QTL (Ap7q, Published QTL, Chr 7)
|
|
GS203335: GO:0048513 organ development
|
|
GS176660: HP:0000050 Hypoplastic genitalia
|
|
GS188684: GO:0070013 intracellular organelle lumen
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS194499: GO:0044271 cellular nitrogen compound biosynthetic process
|
|
GS180164: GO:0008150 biological_process
|
|
GS175333: HP:0000035 Abnormality of the testis
|
|
GS177357: GO:0003676 nucleic acid binding
|
|
GS176333: HP:0007319 Morphological abnormality of the central nervous system
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS169032: MP:0005551 abnormal eye electrophysiology
|
|
GS171651: HP:0000618 Blindness
|
|
GS196540: GO:0043565 sequence-specific DNA binding
|
|
GS186677: GO:0043010 camera-type eye development
|
|
GS168576: MP:0008585 absent photoreceptor outer segment
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS171833: HP:0000119 Abnormality of the genitourinary system
|
|
GS177214: GO:0006366 transcription from RNA polymerase II promoter
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS182475: GO:0043233 organelle lumen
|
|
GS207858: GO:0009059 macromolecule biosynthetic process
|
|
GS188506: GO:0010467 gene expression
|
|
GS164848: MP:0006075 abnormal retinal cone bipolar cell morphology
|
|
GS208012: GO:0044464 cell part
|
|
GS136238: mandible size 5 (Manz5, Published QTL Chr 7)
|
|
GS210212: GO:0005575 cellular_component
|
|
GS195291: GO:0006355 regulation of transcription, DNA-dependent
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS205369: GO:0010468 regulation of gene expression
|
|
GS192073: GO:1901576 organic substance biosynthetic process
|
|
GS165465: MP:0003633 abnormal nervous system physiology
|
|
GS176202: HP:0000479 Abnormality of the retina
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS173020: HP:0000818 Abnormality of the endocrine system
|
|
GS188762: GO:0009889 regulation of biosynthetic process
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS177813: GO:0031974 membrane-enclosed lumen
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS192610: GO:0031981 nuclear lumen
|
|
GS208060: GO:0010557 positive regulation of macromolecule biosynthetic process
|
|
GS209987: GO:0050953 sensory perception of light stimulus
|
|
GS184435: GO:0046483 heterocycle metabolic process
|
|
GS175610: HP:0007994 Peripheral visual field loss
|
|
GS187370: GO:0001071 nucleic acid binding transcription factor activity
|
|
GS200472: GO:0030275 LRR domain binding
|
|
GS186214: GO:0048518 positive regulation of biological process
|
|
GS194038: GO:1901362 organic cyclic compound biosynthetic process
|
|
GS174379: HP:0002084 Encephalocele
|
|
GS170724: MP:0002561 abnormal circadian phase
|
|
GS176101: HP:0000924 Abnormality of the skeletal system
|
|
GS176771: HP:0001000 Abnormality of skin pigmentation
|
|
GS174449: HP:0001123 Visual field defect
|
|
GS171773: HP:0000532 Chorioretinal abnormality
|
|
GS171791: HP:0000370 Abnormality of the middle ear
|
|
GS172195: HP:0000504 Abnormality of vision
|
|
GS135415: bronchial hyperresponsiveness 6 (Bhr6, Published QTL Chr 7)
|
|
GS171656: HP:0000610 Abnormality of the choroid
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS177310: GO:1901360 organic cyclic compound metabolic process
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS210180: GO:0031326 regulation of cellular biosynthetic process
|
|
GS182834: GO:0005623 cell
|
|
GS205622: GO:0009889 regulation of biosynthetic process
|
|
GS163942: MP:0005200 abnormal eye pigment epithelium morphology
|
|
GS191151: GO:0010556 regulation of macromolecule biosynthetic process
|
|
GS209282: GO:0010628 positive regulation of gene expression
|
|
GS189460: GO:0060255 regulation of macromolecule metabolic process
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS178448: GO:0005634 nucleus
|
|
GS175335: HP:0000036 Abnormality of the penis
|
|
GS174914: HP:0003011 Abnormality of the musculature
|
|
GS199635: GO:0005622 intracellular
|
|
GS171461: HP:0011121 Abnormality of skin morphology
|
|
GS167922: MP:0000959 abnormal somatic sensory system morphology
|
|
GS208061: GO:0010556 regulation of macromolecule biosynthetic process
|
|
GS178537: GO:0006355 regulation of transcription, DNA-dependent
|
|
GS165390: MP:0003224 neuron degeneration
|
|
GS196943: GO:0008152 metabolic process
|
|
GS187984: GO:0003682 chromatin binding
|
|
GS173206: HP:0003241 Genital hypoplasia
|
|
GS171968: HP:0000405 Conductive hearing impairment
|
|
GS174075: HP:0009121 Abnormal axial skeleton morphology
|
|
GS196941: GO:0008150 biological_process
|
|
GS135679: Crhr1 transcript abundance QTL 1 (Crhr1taq1, Published QTL Chr 7)
|
|
GS199634: GO:0005623 cell
|
|
GS171900: HP:0011452 Functional abnormality of the middle ear
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS199393: GO:0019904 protein domain specific binding
|
|
GS166481: MP:0008518 retinal outer nuclear layer degeneration
|
|
GS163167: MP:0006074 abnormal retinal rod bipolar cell morphology
|
|
GS175539: HP:0007256 Abnormality of pyramidal motor function
|
|
GS187045: GO:0016070 RNA metabolic process
|
|
GS201256: GO:0044422 organelle part
|
|
GS205616: GO:0009887 organ morphogenesis
|
|
GS210182: GO:0031323 regulation of cellular metabolic process
|
|
GS201431: GO:0005515 protein binding
|
|
GS176613: HP:0000271 Abnormality of the face
|
|
GS173147: HP:0011283 Abnormality of the metencephalon
|
|
GS171975: HP:0000533 Chorioretinal atrophy
|
|
GS175594: HP:0011014 Abnormal glucose homeostasis
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS128573: Ethanol Induced Hypothermia Chr# 7
|
|
GS177761: GO:0044271 cellular nitrogen compound biosynthetic process
|
|
GS136298: maternal performance (Mprf, Published QTL Chr 7)
|
|
GS175016: HP:0001626 Abnormality of the cardiovascular system
|
|
GS190682: GO:0007275 multicellular organismal development
|
|
GS175990: HP:0000463 Anteverted nares
|
|
GS199267: GO:0043234 protein complex
|
|
GS136602: sperm beat cross frequency (Sbcf, Published QTL Chr 7)
|
|
GS181783: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS210181: GO:0031325 positive regulation of cellular metabolic process
|
|
GS176616: HP:0000662 Night blindness
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS183669: GO:0030275 LRR domain binding
|
|
GS202080: GO:0051252 regulation of RNA metabolic process
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS204568: GO:0009893 positive regulation of metabolic process
|